LIDOCAINE AND PRILOCAINE
LIDOCAINE AND PRILOCAINE
Approved
Approval ID
c05f3803-92ae-42b7-8248-933bd92d6116
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jan 20, 2020
Manufacturers
FDA
DIRECT RX
DUNS: 079254320
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
LIDOCAINE AND PRILOCAINE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code61919-443
Application NumberNDA019941
Product Classification
M
Marketing Category
C73594
G
Generic Name
LIDOCAINE AND PRILOCAINE
Product Specifications
Route of AdministrationTOPICAL
Effective DateJanuary 20, 2020
FDA Product Classification
INGREDIENTS (6)
CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED)Inactive
Code: Z135WT9208
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
PEG-55 HYDROGENATED CASTOR OILInactive
Code: 0WZF1506N9
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
LIDOCAINEActive
Quantity: 25 mg in 1 g
Code: 98PI200987
Classification: ACTIB
PRILOCAINEActive
Quantity: 25 mg in 1 g
Code: 046O35D44R
Classification: ACTIB